Literature DB >> 18082514

Prevalence, predictors, time course, and long-term clinical implications of left ventricular functional recovery after mechanical reperfusion for acute myocardial infarction.

Guido Parodi1, Gentian Memisha, Nazario Carrabba, Umberto Signorini, Angela Migliorini, Giampaolo Cerisano, David Antoniucci.   

Abstract

This study prospectively evaluated the prevalence, predictors, time course, and prognostic impact of left ventricular (LV) functional recovery after successful primary percutaneous coronary intervention in 228 consecutive patients with acute myocardial infarctions (AMIs) and LV dysfunction. Serial echocardiographic exams were performed within 24 hours (time 1) and at 1 month (time 2) and 6 months (time 3) after AMI. Overall, 133 patients (58%) showed significant LV functional recovery (> or =10% ejection fraction increase compared with time 1 or ejection fraction > or =50%) at time 3. Early (from time 1 to time 2) and late (from time 2 to time 3) functional recovery patterns were detected in 102 patients (45%) and 31 patients (14%), respectively. Independent predictors of LV functional recovery were enzymatic infarct size (p = 0.0001), time from symptom onset to reperfusion (p = 0.022), extent and severity of baseline LV wall motion abnormalities (p = 0.007), and female gender (p = 0.031). Six-month LV remodeling rates were 36% and 64% in patients with and without LV functional recovery (p = 0.0001). The five-year cardiac death rate was significantly lower in patients with LV functional recovery than in those without (8% vs 18%, respectively, p = 0.024). The time course of LV functional recovery during 6 months did not significantly affect long-term survival. In conclusion, after successful mechanical reperfusion of AMIs, nearly half of patients showed poor LV functional recovery. The presence of significant LV functional recovery 6 months after reperfused AMI, but not the specific time course of recovery, is clearly associated with a better long-term clinical outcome. Simple baseline variables can predict the improvement of cardiac function after reperfused AMI.

Entities:  

Mesh:

Year:  2007        PMID: 18082514     DOI: 10.1016/j.amjcard.2007.07.022

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

1.  Recovery of Left Ventricular Systolic Function and Clinical Outcomes in Young Adults With Myocardial Infarction.

Authors:  Wanda Y Wu; David W Biery; Avinainder Singh; Sanjay Divakaran; Adam N Berman; Gloria Ayuba; Ersilia M DeFilippis; Khurram Nasir; James L Januzzi; Marcelo F Di Carli; Deepak L Bhatt; Ron Blankstein
Journal:  J Am Coll Cardiol       Date:  2020-06-09       Impact factor: 24.094

2.  Growth Differentiation Factor 15 is Related with Left Ventricular Recovery in Patients with ST-Elevation Myocardial Infarction after Successful Reperfusion by Primary Percutaneous Intervention.

Authors:  Mustafa Umut Somuncu; Fatih Pasa Tatar; Belma Kalayci; Ahmet Avci; Naile Eris Gudul; Begum Uygur; Ali Riza Demir; Murat Can
Journal:  Acta Cardiol Sin       Date:  2021-09       Impact factor: 2.672

3.  Left Ventricular Dyssynchrony After Acute Myocardial Infarction is a Powerful Indicator of Left Ventricular Remodeling.

Authors:  Jum Suk Ko; Myung Ho Jeong; Min Goo Lee; Shin Eun Lee; Won Yu Kang; Soo Hyun Kim; Keun-Ho Park; Doo Sun Sim; Nam Sik Yoon; Hyun Ju Yoon; Young Joon Hong; Hyung Wook Park; Ju Han Kim; Youngkeun Ahn; Jeong Gwan Cho; Jong Chun Park; Jung Chaee Kang
Journal:  Korean Circ J       Date:  2009-06-30       Impact factor: 3.243

4.  Equilibrium radionuclide angiography for evaluating the effect of percutaneous coronary intervention on ventricular aneurysm formation and systolic synchrony in patients with acute myocardial infarction.

Authors:  Xue Ling; Fu Xiang-Hua; Liu Jun; Jia Xin-Wei; Wu Wei-Li; Gu Xin-Shun; Ding Chao; Jiang Yun-Fa; Hao Guo-Zhen; Fan Wei-Ze; Zhang Jing
Journal:  Int J Cardiovasc Imaging       Date:  2009-08-12       Impact factor: 2.357

5.  Predictors of ventricular remodelling in patients with reperfused acute myocardial infarction and left ventricular dysfunction candidates for bone marrow cell therapy: insights from the BONAMI trial.

Authors:  Alain Manrique; Patricia Lemarchand; Béatrice Delasalle; Olivier Lairez; Catherine Sportouch-Duckan; Guillaume Lamirault; Philippe Le Corvoisier; Yannick Neuder; Marjorie Richardson; Alain Lebon; Jérome Roncalli; Christophe Piot; Jean-Noel Trochu; Emmanuel Teiger; Claude Hossein-Foucher; Thierry Le Tourneau
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-12-15       Impact factor: 9.236

6.  Predictors and prognostic impact of left ventricular ejection fraction trajectories in patients with ST-segment elevation myocardial infarction.

Authors:  Zhijun Lei; Bingyu Li; Bo Li; Wenhui Peng
Journal:  Aging Clin Exp Res       Date:  2022-02-11       Impact factor: 4.481

7.  Predictors of Left Ventricle Remodeling: Combined Plasma B-type Natriuretic Peptide Decreasing Ratio and Peak Creatine Kinase-MB.

Authors:  Jen-Te Hsu; Chang-Min Chung; Chi-Ming Chu; Yu-Shen Lin; Kuo-Li Pan; Jung-Jung Chang; Po-Chang Wang; Shih-Tai Chang; Teng-Yao Yang; Shih-Jung Jang; Tsung-Han Yang; Ju-Feng Hsiao
Journal:  Int J Med Sci       Date:  2017-01-15       Impact factor: 3.738

8.  Development and course of heart failure after a myocardial infarction in younger and older people.

Authors:  Azam Torabi; John Gf Cleland; Alan S Rigby; Nasser Sherwi
Journal:  J Geriatr Cardiol       Date:  2014-03       Impact factor: 3.327

9.  Effects of no-reflow phenomenon on ventricular systolic synchrony in patients with acute anterior myocardial infarction after percutaneous coronary intervention.

Authors:  Le Wang; Gang Liu; Jun Liu; Mingqi Zheng; Liang Li
Journal:  Ther Clin Risk Manag       Date:  2016-06-24       Impact factor: 2.423

10.  Predictors of decreased left ventricular function subsequent to follow-up echocardiography after percutaneous coronary intervention following acute ST-elevation myocardial infarction.

Authors:  Dong-Hee Kim; Chang-Bum Park; Eun-Sun Jin; Hui-Jeong Hwang; Il Suk Sohn; Jin-Man Cho; Chong-Jin Kim
Journal:  Exp Ther Med       Date:  2018-03-19       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.